In a setback to drug maker GlaxoSmithKline Plc (GSK), an experimental product of the company failed in an advanced test of lung cancer for the second time. The therapy known as MAGE-A3 failed in a cancer study after it didn’t help patients with non-small cell lung cancer live longer without the disease recurring, the London-based company said in a statement today. Amid the setback, the Glaxo … [Read more...]